Health Net Health Plan of Oregon, Inc. Health Net Life Insurance Company 13221 SW 68th Parkway Tigard, Oregon 97223 Phone 888.802.7001 www.healthnet.com
Preferred Drug List (PDL) Changes SECOND QUARTER 2013 - COMMERCIAL PRODUCTS Drug Name (generic name) Tier 1 Additions and Changes Bactroban®
Treatment of impetigo and other skin infections
Adjunctive treatment of partial seizures
Limited to 12 tablets per fill and 2 fills per month
Treatment of depression, panic disorder, bulimia and obsessive
Treatment of depression Removed prior authorization requirement
Treatment of fungal infections Removed prior authorization requirement
Treatment of high cholesterol. Prevention of stroke and heart attack Removed prior authorization requirement. Limited to 1 tablet per day
Tier 2 Additions and Changes Delzicol®
Treatment of iron toxicity Removed prior authorization requirement
Treatment of hepatitis B Removed prior authorization requirement
Treatment of human immunodeficiency virus (HIV) infection Removed prior authorization requirement
Treatment of fungal infections Removed prior authorization requirement
Treatment of infections Removed prior authorization requirement
Tier 3 Additions and Changes Absorica™
Treatment of severe cystic acne Prior authorization required
Prevention and treatment of osteoporosis Limited to 4 tablets per month
Prevention and treatment of osteoporosis Removed prior authorization requirement. Limited to 1 tablet per month
(desloratadine) orally disintegrating Treatment of allergies tablet Crestor® 40mg
Treatment of high cholesterol. Prevention of stroke and heart attack Removed prior authorization requirement. Limited to 1 tablet per day
Treatment of chronic obstructive pulmonary disease (COPD) Removed prior authorization requirement
Treatment of pseudomembranous colitis or Clostridium difficile-associated diarrhea (CDAD) Removed prior authorization requirement
Treatment of ulcerative colitis and Crohn’s disease
Treatment of iron overload Removed prior authorization requirement
Treatment of depression, obsessive compulsive disorder (OCD), bulimia and panic disorder Removed prior authorization requirement. Limited 1 tablet per day
Treatment of homozygous familial hypercholesterolemia Prior authorization required
Treatment of pneumonia Removed prior authorization requirement. Limited to 10 tablets per fill
Adjunctive therapy of seizures Prior authorization required
Treatment of heavy menstrual bleeding Up to 30 tablets per month
Treatment of attention deficit hyperactivity disorder (ADHD)
Treatment of opiate dependence Prior authorization required
Treatment of insomnia Removed prior authorization requirement
Other Additions and Changes Berinert®
Treatment of acute attacks of hereditary angiodema (HAE) Prior authorization required
Treatment of short bowel syndrome (SBS) Prior authorization required
Treatment of homozygous familial hypercholesterolemia Prior authorization required
Treatment of advanced renal cell cancer and liver cancer Removed prior authorization requirement
Treatment of multiple myeloma Prior authorization required
Treatment of leukemia Removed prior authorization requirement
Treatment of renal cell cancer, pancreatic neuroendocrine tumor (PNET) and gastrointestinal stromal tumors (GIST) Removed prior authorization requirement
Treatment of advanced breast cancer Removed prior authorization requirement
PDL AT WWW.HEALTHNET.COM Please be sure to visit our websrrent version of our PDL. FOR QUESTIONS REGARDING THE INFORMATION IN THIS UPDATE, PLEASE CONTACT THE HEALTH NET PHARMACY DEPARTMENT AT 1-888-802-7001, OPTION 1, THEN OPTION 4.
Pharmacy and Pharmaceutical Technology Department 10th-12th March 2003 Parametric and nonparametric population PK and PD modelling. Aplications in Therapeutic Drug Monitoring 12:00 Continous response modelling. Dra. A. Aldaz. Faculty 12:30 The behaviour of Efavirenz. Dr. NV Jimenez Torres. Azucena Aldaz Pastor , Facultad de Farmacia, Universidad 10 de Marzo d